HK woman dies, 3 hospitalized by beauty treatment

October 11, 2012 in Health

(AP)—Hong Kong authorities said one woman has died and three others have been hospitalized after undergoing a beauty treatment involving blood transfusions.

Hong Kong's Hospital Authority said a 46-year-old woman died Wednesday of septic shock after receiving the treatment at a beauty clinic. The treatment is being tested as a method to fight cancer but in this case it was used for cosmetic purposes.

The case has raised concerns about potentially risky medical treatments at the city's numerous clinics offering procedures that claim to enhance a person's appearance.

Health Secretary Ko Wing-man promised Thursday to review regulations governing the clinics and other private medical facilities. Ko said the review would look at putting private clinics that carry out "high risk medical treatments or procedures under regulatory control."

Health authorities are investigating whether a registered doctor carried out the treatment and whether the procedure was certified by Hong Kong's Medical Council.

The four also tested positive for a rare superbug called mycobacterium abscessus, which is extremely resistant to antibiotics.

The three women in hospitals are a 64-year-old in critical condition, a 56-year-old in serious condition and a 59-year-old in stable condition.

They were among 44 people who underwent the treatment at the DR Beauty chain of clinics. The treatment costs at least 50,000 Hong Kong dollars ($6,450), according to local news reports.

The procedure, known as DC-CIK, involves the "concentration and processing" of blood by a lab before it is re-injected into the person it was drawn from, the government said. It is being tested as a way of raising the survival rate of cancer patients after they have surgery, radiation therapy or chemotherapy.

Beauty clinics offering the treatment in Hong Kong promise that it will make people look more youthful, with whiter skin and smaller pores, and strengthen their immune system. But the procedure does not appear to have any proven cosmetic effect.

Police and health officials are jointly investigating how the blood was contaminated and the relationship between the beauty clinic, the blood treatment lab and the medical practitioner who carried out the procedure.

DR Beauty said in a statement on its website that the doctor who carried out the procedures was not employed by the clinic.

Police Commissioner Andy Tsang said officers are treating the death as a criminal case and may consider manslaughter charges, according to local broadcaster RTHK.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Life expectancy gap widens between those with mental illness and general population

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Health created 10 hours ago | popularity not rated yet | comments 0

Failure to use linked health records may lead to biased disease estimates

Failure to use linked electronic health records may lead to biased estimates of heart attack incidence and outcome, warn researchers in a paper published in BMJ today.

Health created 10 hours ago | popularity 5 / 5 (1) | comments 0

Dietary advice on added sugar is damaging our health, warns heart expert

Dietary advice on added sugar is damaging our health, warns a cardiologist in BMJ today. Dr. Aseem Malhotra believes that "not only has this advice been manipulated by the food industry for profit but it is actually a risk ...

Health created 10 hours ago | popularity 5 / 5 (4) | comments 0

CDC presents recent trends in health behaviors of US adults

(HealthDay)—In 2008 to 2010, the prevalence of key health behaviors among U.S. adults varied, with about one in five adults current smokers and 62.1 percent overweight or obese, according to a report presented ...

Health created 13 hours ago | popularity 5 / 5 (1) | comments 0

Americans still making unhealthy choices, CDC reports

(HealthDay)—The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or ...

Health created 13 hours ago | popularity not rated yet | comments 0


Study says empathy plays a key role in moral judgments

Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...

Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens

Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.